Cilli, A. Et Al. 2021. Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis. PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.71 .

Cilli, A., Uzer, F., Sevinç, C., Coşkun, F., Ursavaş, A., Öner, Ş., ... Kose, F.(2021). Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis. PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.71.

Cilli, Aykut Et Al. "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis," PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.71, 2021

Cilli, Aykut Et Al. "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis." PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.71, 2021

Cilli, A. Et Al. (2021) . "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis." PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.71.

@article{article, author={Aykut Cilli Et Al. }, title={Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis}, journal={PULMONARY PHARMACOLOGY & THERAPEUTICS}, year=2021}